Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Symbol
SPRB
Shares outstanding
1,077,462 shares
Disclosed Ownership
70,035 shares
Ownership
6.5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:37:48 UTC
Date of event
31 Dec 2025
Previous filing
16 Oct 2025

Sponsored

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 6.5% ownership in Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") (SPRB) on 31 Dec 2025."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G/A for Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") (SPRB).
  • Disclosed ownership: 6.5%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 16 Oct 2025.
  • Current filing was accepted on 17 Feb 2026, 16:37.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 6.5% 69,999 0 69,999 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 6.5% 69,999 0 69,999 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 6.5% 69,999 0 69,999 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 36 0 36 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 0% 36 0 36 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 0% 36 0 36 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 6.5% 70,035 0 70,035 /s/ Seth Levy Seth Levy, attorney-in-fact*